Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.
Cancers (Basel). 2021 Jul 3;13(13):3343. doi: 10.3390/cancers13133343.
Cancers (Basel). 2021.
PMID: 34283076
Free PMC article.
Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.
Zheng M, Mullikin H, Hester A, Czogalla B, Heidegger H, Vilsmaier T, Vattai A, Chelariu-Raicu A, Jeschke U, Trillsch F, Mahner S, Kaltofen T.
Zheng M, et al. Among authors: mullikin h.
Int J Mol Sci. 2020 Dec 1;21(23):9169. doi: 10.3390/ijms21239169.
Int J Mol Sci. 2020.
PMID: 33271935
Free PMC article.
Item in Clipboard
Expression of trophoblast derived prostaglandin E2 receptor 2 (EP2) is reduced in patients with recurrent miscarriage and EP2 regulates cell proliferation and expression of inflammatory cytokines.
Peng L, Ye Y, Mullikin H, Lin L, Kuhn C, Rahmeh M, Mahner S, Jeschke U, von Schönfeldt V.
Peng L, et al. Among authors: mullikin h.
J Reprod Immunol. 2020 Nov;142:103210. doi: 10.1016/j.jri.2020.103210. Epub 2020 Oct 1.
J Reprod Immunol. 2020.
PMID: 33011635
Item in Clipboard
Cite
Cite